Skip to main content
. 2020 Jun 1;58(4):264–269. doi: 10.1136/jmedgenet-2019-106562

Figure 2.

Figure 2

Cumulative pancreatic cancer incidence for c.67G>C, p.(Gly23Arg) carriers, with 95% CIs shown as dashed lines.